Itamar Medical Ltd - ADR

0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)498.19M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$13.45 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$30.32
50-Day MA$25.89
200-Day MA$23.40
See more pivots

Itamar Medical Ltd - ADR Stock, NASDAQ:ITMR

9 Halamish Street, Caesarea, Haifa 3079883
Phone: +972.4.617.7000
Number of Employees: 257


Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.